samedan logo
 
 
spacer
home > pmps > spring 2003 > drug counterfeiting epidemic spurs urgent need for co-operation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Drug Counterfeiting Epidemic Spurs Urgent Need For Co-Operation

Over 200 government officials, packagers and pharmaceutical industry heads joined in a resounding call for a large-scale collaboration to combat the growing drug counterfeiting problem - a practice which could be responsible for hundreds of thousands of deaths per year. The event, entitled the Global Forum on Pharmaceutical Counterfeiting, took place on the 22nd-25th September in Geneva, and set out to gather views on the drug counterfeiting problem, which is now being considered an epidemic. Fake drugs are a weapon of mass human destruction, said Robert Cockburn, an independent journalist who investigated global drug counterfeiting over the last decade.

After witnessing Beirut in 1982 and other war zones writing for the UK's Guardian newspaper, he said the deadliness of drug counterfeiting is less surprising than the ease with which counterfeiters perform their work. "If [counterfeit drugs] could be seen, not as trade violation, but as vehicles of terror, there would be a war against them tomorrow." But there are no votes in fighting fake drugs, he concluded - this war is much tougher. Criminals don't respect borders or trademarks so organisations need to collaborate across national and commercial competitive boundaries to be effective. And there is strength in numbers, says Ian Lancaster, a Principal of Reconnaissance International.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jonathan Senft, Reconnaissance International

Jonathan Senft is a writer for Reconnaissance International, publisher of Holography News, Authentication News and Currency News. He also works on an anticounterfeiting research project with the US Food and Drug Administration. Mr Senft, who attended university in Illinois and Massachusetts, has written for various trade and legal publications over the last six years.

spacer
Jonathan Senft
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cerba Research and ACT Genomics Announce Strategic Joint Venture CerbACT Asia

This expansion of the precision medicine offering includes central labs, flow cytometry, histopathology, and translational science laboratory services. Deep scientific expertise from both sides of this strategic alliance will support new growth areas for biotech and pharma clients globally and drive better patient outcomes across all phases of clinical trials.
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement